SB
About
Sharon Barr is the Executive Vice President, BioPharmaceuticals R&D of AstraZeneca. She previously worked at Alexion Pharmaceuticals, Inc. as a Senior Vice President, Head of Research, Data Sciences, Bioinformatics and Diagnostics. Sharon Barr attended Stanford University School of Medicine.
Position in the VCSift Database
- • 7 investors at AstraZeneca are tracked.
- • 1 investors hold the Executive Vice President, BioPharmaceuticals R&D role in VCSift. Sharon Barr is one of them.
- • 2,799 investors are based in United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- US
Contact Information
linkedin.com/in/••••••••
Find more investors like Sharon
Search Investors